Merck (MRK) Tops Q2 EPS by 33c, Updates FY Guidance

July 31, 2020 6:46 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Merck (NYSE: MRK) reported Q2 EPS of $1.37, $0.33 better than the analyst estimate of $1.04. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $10.39 billion.

GUIDANCE:

Merck sees FY2020 EPS of $5.63-$5.78, versus the consensus of $5.31. Merck sees FY2020 revenue of $47.2-48.7 billion, versus the consensus of $47.3 billion.

For earnings history and earnings-related data on Merck (MRK) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings

Related Entities

Earnings